Podcast: Pascal Ronfard on the prebiotic contribution to gut health

By Will Chu

- Last updated on GMT

Podcast: Pascal Ronfard on the prebiotic contribution to gut health

Related tags Podcast Ronfard Solactis Greentech Prebiotic

In this month’s NutraIngredients’ podcast, Solactis’ Pascal Ronfard took time out to discuss the role of prebiotics in promoting gut health and immune function.

Pascal Ronfard profile pic
Pascal Ronfard, Deputy Managing Director at Solactis. ©PascalRonfard

Ronfard has been Deputy Managing Director of Solactis Group, a France-based supplier of ingredients such as galactofructose, probiotics and microalgae.

The Group, based in Saint Beauzire in central France, recently welcomed French biotechnology firm, The Greentech Group to the firm, who took a majority stake in Solactis back in May.

Commenting on the deal, Ronfard says, “Solactis needs to have access to the raw materials to produce the prebiotic. By joining forces with Greentech, we have access to plant extracts, microalgae and the carbohydrates and polyphenols it contains.”

'Synergy between the firms.'

“There is also a Greentech division developing bacterial strains, that is paving the way for development of prebiotics and probiotics for the internal commensal flora or endogenously, which will be developed in our factory or jointly with Greentech. There is a lot of synergy between the two of us.”

With the new agreement, Solactis also now look to offer new oligosaccharides as well as new probiotic bacteria to be used in infant formulas.

“Customers are more aware of the microbiota’s role in health nowadays and are looking for ingredients in their product that will deliver improvements to the gut and its community.

“In infant formula, it is certain that you build the gut microbiome in the first weeks or months of life, so it is definitely a key issue.”

Podcast music by John_Sib​​ from Pixabay

Related news

Related products

show more

New digestive wellness solution with clinical evidence

New digestive wellness solution with clinical evidence

Content provided by Symrise AG | 31-May-2024 | Product Brochure

16% of adults across the globe are suffering from constipation¹. Functional gastrointestinal disorders are a worldwide issue, impacting the life of 15,2%...

Related suppliers

Follow us


View more